SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Hester Biosciences informs about credit rating

09 Jan 2020 Evaluate

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Hester Biosciences has informed that CARE Ratings, with its letter dated 8 January 2020 (received by Company on 9 January 2020), has revised the ratings to the Company. The revision in credit ratings were issued due to additional term loan facility sanctioned by the Bank.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1461.00 -18.25 (-1.23%)
24-Apr-2026 10:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1625.90
Dr. Reddys Lab 1307.20
Cipla 1290.65
Zydus Lifesciences 923.30
Lupin 2306.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×